Meeder Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Meeder Asset Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,837	Closed	-$16K	–	2635
2019 Q4	$16K	Sell	1,837 -515	-22%	-$4.02K	﹤0.01%	1430
2019 Q3	$16K	Buy	2,352 +1,339	+132%	+$9.82K	﹤0.01%	1397
2019 Q2	$8K	Sell	1,013 -10,909	-92%	-$94.1K	﹤0.01%	1541
2019 Q1	$109K	Buy	11,922 +1,706	+17%	+$17.3K	0.01%	682
2018 Q4	$111K	Buy	10,216 +1,518	+17%	+$19.1K	0.01%	615
2018 Q3	$122K	Buy	8,698 +4,122	+90%	+$55.8K	0.01%	603
2018 Q2	$48.7K	Buy	4,576 +3,564	+352%	+$34.8K	﹤0.01%	762
2018 Q1	$7K	Buy	+1,012	New	+$8.88K	﹤0.01%	1164

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Meeder Asset Management's KIN Position: Q1 2020 in Review

Meeder Asset Management sold out of Kindred Biosciences, Inc. (KIN) in Q1 2020, closing a stake of 1,837 shares — an estimated $16K sold.

Meeder Asset Management first reported a position in KIN in Q1 2018 and held it in 8 quarters. The position peaked at $122K in Q3 2018. 77 funds tracked by Wall St. Rank hold KIN as of Q1 2020.

Meeder Asset Management reported no remaining Kindred Biosciences, Inc. position as of Q1 2020 after selling out during the quarter.
Meeder Asset Management sold 1,837 Kindred Biosciences, Inc. shares in Q1 2020, an estimated $16K.
Meeder Asset Management first reported a position in Kindred Biosciences, Inc. in Q1 2018 and held it in 8 quarters.
Meeder Asset Management's Kindred Biosciences, Inc. position peaked at $122K in Q3 2018.
77 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2020.

Based on Meeder Asset Management's 13F filing for Q1 2020, filed 15 May 2020.